| Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2025-05-15 14:50:30 |
Czytaj oryginał (ang.) |
| Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2025-05-14 14:41:04 |
Czytaj oryginał (ang.) |
| DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract |
Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment. |
zacks.com |
2025-05-13 17:15:39 |
Czytaj oryginał (ang.) |
| DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript |
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito Chickering - Deutsche Bank A.J. Rice - UBS Ryan Langston - TD Cowen Operator Good evening. |
seekingalpha.com |
2025-05-13 01:41:18 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates |
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago. |
zacks.com |
2025-05-12 22:20:54 |
Czytaj oryginał (ang.) |
| DaVita beats quarterly profit estimates amid stable demand for dialysis services |
DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services. |
reuters.com |
2025-05-12 21:37:59 |
Czytaj oryginał (ang.) |
| DaVita First-Quarter 2025 Financial Results: Just the Numbers |
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below. |
investopedia.com |
2025-05-12 20:51:08 |
Czytaj oryginał (ang.) |
| DaVita Inc. 1st Quarter 2025 Results |
DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders. |
prnewswire.com |
2025-05-12 20:05:00 |
Czytaj oryginał (ang.) |
| Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings? |
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance. |
zacks.com |
2025-05-08 16:55:31 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know |
DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session. |
zacks.com |
2025-05-07 23:00:39 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know |
DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day. |
zacks.com |
2025-05-01 23:06:31 |
Czytaj oryginał (ang.) |
| DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call |
DENVER , April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. |
prnewswire.com |
2025-04-30 15:00:00 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note |
In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day. |
zacks.com |
2025-04-22 23:05:33 |
Czytaj oryginał (ang.) |
| 3 No-Brainer Warren Buffett Stocks to Buy Right Now |
In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has weathered every market storm and consistently outperformed market benchmarks. |
fool.com |
2025-04-19 08:30:00 |
Czytaj oryginał (ang.) |
| Why DaVita Stock Got Rocked This Week |
We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors. |
fool.com |
2025-04-18 22:13:28 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors |
DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close. |
zacks.com |
2025-04-17 23:20:29 |
Czytaj oryginał (ang.) |
| DaVita Says Ransomware Attack Affecting Some Operations |
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations. |
wsj.com |
2025-04-14 11:35:00 |
Czytaj oryginał (ang.) |
| Dialysis firm DaVita hit by ransomware attack |
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach. |
reuters.com |
2025-04-14 11:33:54 |
Czytaj oryginał (ang.) |
| 4 Stocks to Watch in a Dynamic Outpatient Home Health Industry |
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain. |
zacks.com |
2025-04-10 06:35:28 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know |
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close. |
zacks.com |
2025-04-01 23:20:44 |
Czytaj oryginał (ang.) |
| YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities |
CHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita, a leading provider of comprehensive kidney care, to advance chronic disease education and prevention for individuals and their families who are either managing or at risk for chronic kidney disease (CKD). CKD disproportionately affects individuals with risk factors such as hypertension and diabetes. |
globenewswire.com |
2025-02-27 11:00:00 |
Czytaj oryginał (ang.) |
| Here's why this Warren Buffett stock plunged 11% in a day |
Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and ongoing dialysis center closures. |
finbold.com |
2025-02-17 10:13:07 |
Czytaj oryginał (ang.) |
| Why DaVita Inc Stock Is Plummeting Today |
Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day. |
fool.com |
2025-02-14 19:25:00 |
Czytaj oryginał (ang.) |
| DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping. |
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis. |
marketwatch.com |
2025-02-14 15:01:00 |
Czytaj oryginał (ang.) |
| Here's why Warren Buffett dumped $31 million worth of this stock |
Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO) and chairman did so by utilizing a careful, level-headed approach to investing. |
finbold.com |
2025-02-14 10:41:12 |
Czytaj oryginał (ang.) |
| Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance |
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement. |
cnbc.com |
2025-02-14 10:16:08 |
Czytaj oryginał (ang.) |
| DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript |
DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Joanna Gajuk - Bank of America AJ Rice - UBS Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good evening. My name is Michelle, and I will be your conference facilitator today. |
seekingalpha.com |
2025-02-13 22:19:29 |
Czytaj oryginał (ang.) |
| Berkshire sells some DaVita shares, cuts stake to 45% |
Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion. |
reuters.com |
2025-02-13 22:13:02 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates |
DaVita HealthCare (DVA) came out with quarterly earnings of $2.24 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.87 per share a year ago. |
zacks.com |
2025-02-13 20:21:12 |
Czytaj oryginał (ang.) |
| DaVita forecasts 2025 profit below estimates, shares plummet |
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading. |
reuters.com |
2025-02-13 20:07:08 |
Czytaj oryginał (ang.) |
| DaVita Inc. 4th Quarter 2024 Results |
DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25th anniversary of DaVita, we look forward to continuing our efforts to improve clinical outcomes, enhance quality of life for our patients and teammates, and be a force for positive change in the healthcare system. |
prnewswire.com |
2025-02-13 18:05:00 |
Czytaj oryginał (ang.) |
| DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock? |
Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance. |
zacks.com |
2025-02-12 13:31:42 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know |
The latest trading day saw DaVita HealthCare (DVA) settling at $177.35, representing a +0.16% change from its previous close. |
zacks.com |
2025-02-04 21:05:39 |
Czytaj oryginał (ang.) |
| 2 Warren Buffett Stocks to Buy Without Hesitation If You Have $1,000 to Invest Right Now |
The Oracle of Omaha, Warren Buffett, is arguably one of the most famous investors of all time. Many investors have sought to replicate his investing strategy as emphasized by the holdings of Buffett's multinational conglomerate Berkshire Hathaway. |
fool.com |
2025-02-02 12:00:00 |
Czytaj oryginał (ang.) |
| 3 No-Brainer Warren Buffett Stocks to Buy Right Now |
Warren Buffett has built a track record of investing success going back 60 years. Despite his advanced age and the increased influence of other investors at Berkshire Hathaway, investment decisions made by his company carry significant weight with average investors. |
fool.com |
2025-02-02 06:05:00 |
Czytaj oryginał (ang.) |
| 4 Stocks Trading Near 52-Week High With Room to Rise Further |
Investors target stocks that have been on a bullish run lately. Stocks like ENS, DVA, REVG and PAA are seeing price strength and the momentum is likely to continue. |
zacks.com |
2025-01-31 10:51:14 |
Czytaj oryginał (ang.) |
| DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call |
DENVER , Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. |
prnewswire.com |
2025-01-30 13:55:00 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note |
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $173.77, denoting a +0.32% change from the preceding trading day. |
zacks.com |
2025-01-29 21:05:31 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why |
DaVita HealthCare (DVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-01-29 15:01:11 |
Czytaj oryginał (ang.) |
| Sell Nvidia, Buy This Stock |
Big things happened this weekend. |
zacks.com |
2025-01-27 16:20:26 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy DaVita (DVA) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-01-02 12:40:25 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Laps the Stock Market: Here's Why |
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $155.06, denoting a +1.33% change from the preceding trading day. |
zacks.com |
2024-12-24 21:00:36 |
Czytaj oryginał (ang.) |
| The Best Warren Buffett Stocks to Buy With $250 Right Now |
Warren Buffett is recognized for his legendary ability to uncover high-quality and undervalued companies to invest in. Under his leadership, Berkshire Hathaway (BRK.B 0.86%) (BRK.A 1.37%) has crushed the returns of stock market benchmarks like the S&P 500 index. |
fool.com |
2024-12-22 06:47:00 |
Czytaj oryginał (ang.) |
| DaVita Stock Gains 40.1% Year to Date: What's Behind the Rally? |
Strength in kidney care services and expansion into international markets raise optimism for DVA stock. |
zacks.com |
2024-12-19 10:46:22 |
Czytaj oryginał (ang.) |
| The Best Warren Buffett Stocks to Buy With $1,000 Right Now |
Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchmark return. These exceptional results stem from Buffett and his late partner Charlie Munger's business acumen, combined with Berkshire's ability to strategically invest funds generated by its insurance business. |
fool.com |
2024-11-25 10:00:00 |
Czytaj oryginał (ang.) |
| DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation |
Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential policy changes. The company's recent financial performance, including a decline in net income and increased debt costs, underscores my conservative valuation approach. |
seekingalpha.com |
2024-11-14 16:19:53 |
Czytaj oryginał (ang.) |
| DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health |
More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER , Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With Purpose (MIWP) event with more than 8,300 participants, including DaVita teammates, friends, family and key members of the kidney care community. The month-long initiative encourages physical activity — whether it's walking, running, swimming, bicycling or other activities — to benefit Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease globally. |
prnewswire.com |
2024-11-12 11:05:00 |
Czytaj oryginał (ang.) |
| DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 |
DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To view the live webcast, visit the UBS page here and create a free registration. |
prnewswire.com |
2024-11-08 18:33:00 |
Czytaj oryginał (ang.) |
| Why DaVita Stock Withered on Wednesday |
The company's profitability is going in the wrong direction for many investors. |
fool.com |
2024-10-30 20:38:00 |
Czytaj oryginał (ang.) |
| Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due |
This week marks a fire hose of earnings from several top Warren Buffett stock holdings. "Extraordinary business" Apple is on deck Thursday. |
investors.com |
2024-10-30 15:53:35 |
Czytaj oryginał (ang.) |
| DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up |
DVA's robust Dialysis patient service revenues drives its third-quarter performance. |
zacks.com |
2024-10-30 14:50:25 |
Czytaj oryginał (ang.) |
| DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript |
DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays AJ Rice - UBS Pito Chickering - Deutsche Bank Lisa Clive - Bernstein Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Justin Lake - Wolfe Research Operator Good evening. My name is Michelle and I will be your conference facilitator today. |
seekingalpha.com |
2024-10-29 23:27:07 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Q3 Earnings Miss Estimates |
DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago. |
zacks.com |
2024-10-29 20:16:21 |
Czytaj oryginał (ang.) |
| DaVita misses third-quarter profit estimates on higher costs |
DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs. |
reuters.com |
2024-10-29 18:23:14 |
Czytaj oryginał (ang.) |
| DaVita Inc. 3rd Quarter 2024 Results |
DENVER , Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of our patients and our frontline caregivers. |
prnewswire.com |
2024-10-29 18:05:00 |
Czytaj oryginał (ang.) |
| 6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week |
If you had to choose the best time to invest in the S&P 500 — it's the six months starting in November. |
investors.com |
2024-10-29 10:00:32 |
Czytaj oryginał (ang.) |
| DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program |
The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones DENVER , Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program, a program that provides social and emotional support for patients, care partners, and living donors through connections with mentors living through similar experiences. Prioritizing mental health in chronic disease care is essential, and mentorship can help provide people with support and comfort in a time when they might otherwise feel alone. |
prnewswire.com |
2024-10-28 13:05:00 |
Czytaj oryginał (ang.) |
| DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock? |
Improvement in RPT is likely to have boosted DaVita's top line in the third quarter. |
zacks.com |
2024-10-25 17:20:26 |
Czytaj oryginał (ang.) |
| DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 |
DENVER and SAN DIEGO , Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative research projects at the American Society of Nephrology (ASN)'s annual Kidney Week meeting, which is currently underway in San Diego, CA. With a focus on improving racial equity in transplantation and key measures of clinical quality such as hospitalizations, DCR works to tackle pressing issues in nephrology that affect diverse populations. |
prnewswire.com |
2024-10-23 14:00:00 |
Czytaj oryginał (ang.) |
| DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know |
DaVita HealthCare (DVA) concluded the recent trading session at $163.16, signifying a +1% move from its prior day's close. |
zacks.com |
2024-10-22 23:21:12 |
Czytaj oryginał (ang.) |